Back

Sacubitril valsartan, ivabradine and omecamtic mecarbil.

5 December 2020 (15:40 - 15:50)
Organised by:
Congress Presentation Part of: New therapies in heart failure with reduced ejection fraction: For whom and when? Chronic Heart Failure ESC Premium Access ESC Asia with APSC & AFC 2020

About the speaker

Photo
Professor Michel Komajda

Groupe Hospitalier Paris Saint-Joseph, Paris (France)

2 More presentations in this session

Presentation thumbnail
Vericiguat and SGLT2 inhibitors.
Professor C. Lam (Singapore, SG)
Video
Presentation thumbnail
New therapies in heart failure with reduced ejection fraction: For whom and when?
Video

Access the full session

Session thumbnail
New therapies in heart failure with reduced ejection fraction: For whom and when?
Video

The Event

Event poster

ESC Asia with APSC & AFC 2020

5 December 2020 15:40 CET
You may be interested in
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
thumbnail
Congress Session
Nursing and Allied Professions Investigator Award
thumbnail
Congress Session
Which device might help your HFpEF patient?

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources